Comparison of efficacy of vaginal misoprostol 100 micrograms versus 200 micrograms for cervical priming prior to operative hysteroscopy â?? a randomized control trial.

Internal Fluid Research0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: - Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Health Condition 1: - Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Sponsor: Internal Fluid Research
Status: Not yet recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Investigators

Sponsor

Internal Fluid Research

Eligibility Criteria

Inclusion Criteria

•Patients requiring operative hysteroscopy for intrauterine cavitory pathologies based on transvaginal ultrasound.

Exclusion Criteria

•1\. Contraindications to hysteroscopy (i.e. pregnancy, cervical malignancy, recent or recurrent pelvic inflammatory disease, marked cervical stenosis, profuse uterine bleeding or recent uterine perforation etc.)
•2\. Any possible contraindications to use of prostaglandins (known sensitivity to prostaglandins, cardiovascular disease, renal failure, severe bronchial asthma, glaucoma etc.)
•3\. Previous cervical surgery
•4\. Presence of significant uterovaginal prolapse impairing vaginal administration.
•5\. Unmarried women where administration of vaginal misoprostol cannot be done.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting

Not Applicable

Comparing a vaginal tablet (Misoprostol) and device (Dilapan) kept inside the cervix for dilatation of cervix before operative hysterosocpic proceduresHealth Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified

CTRI/2020/04/024844Jawaharlal Institute of Postgraduate Medical Education and Research

Recruiting

Phase 3

The Effect of Laminaria with Vaginal Misoprostol on Cervical Preparation in Induction of Second Trimester Abortio

IRCT20190529043759N1Zahedan University of Medical Sciences90

Recruiting

Phase 3

Comparison of the effect of vaginal misoprostol and Evening primrose Capsule on the state of deliveryormal Vaginal Delivery.

IRCT20210113050028N2Ardabil University of Medical Sciences30

Not yet recruiting

Not Applicable

Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal deaththe consequences of abortion in women with intrauterine fetal death.Medical abortion : complete or unspecified, without complicationO04.9

IRCT20181207041873N3Iran University of Medical Sciences84

Completed

Phase 2

Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy proceduresAbnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecified

IRCT2015112821506N4Iran University of Medical Sciences100